Global Long-Acting Injectable Antipsychotics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 123 pages | ID: G621F66B93BEN
GlobalInfoResearch

Abstracts

Scope of the Report:

The global Long-Acting Injectable Antipsychotics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Long-Acting Injectable Antipsychotics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Long-Acting Injectable Antipsychotics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Long-Acting Injectable Antipsychotics market by product type and applications/end industries.

Market Segment by Companies, this report covers

• Eli Lilly
• Pfizer
• GlaxoSmithKline
• Johnson & Johnson
• Lupin Limited
• Zogenix
• DURECT
• Medincel

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Small and Middle Sized Molecule
• Large Sized Molecule

Market Segment by Applications, can be divided into

• Schizophrenia
• Other Psychotic Disorders

Contents

1 LONG-ACTING INJECTABLE ANTIPSYCHOTICS MARKET OVERVIEW

1.1 Product Overview and Scope of Long-Acting Injectable Antipsychotics
1.2 Classification of Long-Acting Injectable Antipsychotics by Types
  1.2.1 Global Long-Acting Injectable Antipsychotics Revenue Comparison by Types (2017-2023)
  1.2.2 Global Long-Acting Injectable Antipsychotics Revenue Market Share by Types in 2017
  1.2.3 Small and Middle Sized Molecule
  1.2.4 Large Sized Molecule
1.3 Global Long-Acting Injectable Antipsychotics Market by Application
  1.3.1 Global Long-Acting Injectable Antipsychotics Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Schizophrenia
  1.3.3 Other Psychotic Disorders
1.4 Global Long-Acting Injectable Antipsychotics Market by Regions
  1.4.1 Global Long-Acting Injectable Antipsychotics Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Long-Acting Injectable Antipsychotics Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Long-Acting Injectable Antipsychotics Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Long-Acting Injectable Antipsychotics Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Long-Acting Injectable Antipsychotics Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Long-Acting Injectable Antipsychotics Status and Prospect (2013-2023)
1.5 Global Market Size of Long-Acting Injectable Antipsychotics (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Eli Lilly
  2.1.1 Business Overview
  2.1.2 Long-Acting Injectable Antipsychotics Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Eli Lilly Long-Acting Injectable Antipsychotics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
  2.2.1 Business Overview
  2.2.2 Long-Acting Injectable Antipsychotics Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Pfizer Long-Acting Injectable Antipsychotics Revenue, Gross Margin and Market Share (2016-2017)
2.3 GlaxoSmithKline
  2.3.1 Business Overview
  2.3.2 Long-Acting Injectable Antipsychotics Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 GlaxoSmithKline Long-Acting Injectable Antipsychotics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Johnson & Johnson
  2.4.1 Business Overview
  2.4.2 Long-Acting Injectable Antipsychotics Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Johnson & Johnson Long-Acting Injectable Antipsychotics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Lupin Limited
  2.5.1 Business Overview
  2.5.2 Long-Acting Injectable Antipsychotics Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Lupin Limited Long-Acting Injectable Antipsychotics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Zogenix
  2.6.1 Business Overview
  2.6.2 Long-Acting Injectable Antipsychotics Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Zogenix Long-Acting Injectable Antipsychotics Revenue, Gross Margin and Market Share (2016-2017)
2.7 DURECT
  2.7.1 Business Overview
  2.7.2 Long-Acting Injectable Antipsychotics Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 DURECT Long-Acting Injectable Antipsychotics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Medincel
  2.8.1 Business Overview
  2.8.2 Long-Acting Injectable Antipsychotics Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Medincel Long-Acting Injectable Antipsychotics Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL LONG-ACTING INJECTABLE ANTIPSYCHOTICS MARKET COMPETITION, BY PLAYERS

3.1 Global Long-Acting Injectable Antipsychotics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Long-Acting Injectable Antipsychotics Players Market Share
  3.2.2 Top 10 Long-Acting Injectable Antipsychotics Players Market Share
3.3 Market Competition Trend

4 GLOBAL LONG-ACTING INJECTABLE ANTIPSYCHOTICS MARKET SIZE BY REGIONS

4.1 Global Long-Acting Injectable Antipsychotics Revenue and Market Share by Regions
4.2 North America Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
4.3 Europe Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
4.5 South America Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA LONG-ACTING INJECTABLE ANTIPSYCHOTICS REVENUE BY COUNTRIES

5.1 North America Long-Acting Injectable Antipsychotics Revenue by Countries (2013-2018)
5.2 USA Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
5.3 Canada Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
5.4 Mexico Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)

6 EUROPE LONG-ACTING INJECTABLE ANTIPSYCHOTICS REVENUE BY COUNTRIES

6.1 Europe Long-Acting Injectable Antipsychotics Revenue by Countries (2013-2018)
6.2 Germany Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
6.3 UK Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
6.4 France Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
6.5 Russia Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
6.6 Italy Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC LONG-ACTING INJECTABLE ANTIPSYCHOTICS REVENUE BY COUNTRIES

7.1 Asia-Pacific Long-Acting Injectable Antipsychotics Revenue by Countries (2013-2018)
7.2 China Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
7.3 Japan Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
7.4 Korea Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
7.5 India Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA LONG-ACTING INJECTABLE ANTIPSYCHOTICS REVENUE BY COUNTRIES

8.1 South America Long-Acting Injectable Antipsychotics Revenue by Countries (2013-2018)
8.2 Brazil Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
8.3 Argentina Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
8.4 Colombia Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE LONG-ACTING INJECTABLE ANTIPSYCHOTICS BY COUNTRIES

9.1 Middle East and Africa Long-Acting Injectable Antipsychotics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
9.3 UAE Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
9.4 Egypt Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
9.6 South Africa Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)

10 GLOBAL LONG-ACTING INJECTABLE ANTIPSYCHOTICS MARKET SEGMENT BY TYPE

10.1 Global Long-Acting Injectable Antipsychotics Revenue and Market Share by Type (2013-2018)
10.2 Global Long-Acting Injectable Antipsychotics Market Forecast by Type (2018-2023)
10.3 Small and Middle Sized Molecule Revenue Growth Rate (2013-2023)
10.4 Large Sized Molecule Revenue Growth Rate (2013-2023)

11 GLOBAL LONG-ACTING INJECTABLE ANTIPSYCHOTICS MARKET SEGMENT BY APPLICATION

11.1 Global Long-Acting Injectable Antipsychotics Revenue Market Share by Application (2013-2018)
11.2 Long-Acting Injectable Antipsychotics Market Forecast by Application (2018-2023)
11.3 Schizophrenia Revenue Growth (2013-2018)
11.4 Other Psychotic Disorders Revenue Growth (2013-2018)

12 GLOBAL LONG-ACTING INJECTABLE ANTIPSYCHOTICS MARKET SIZE FORECAST (2018-2023)

12.1 Global Long-Acting Injectable Antipsychotics Market Size Forecast (2018-2023)
12.2 Global Long-Acting Injectable Antipsychotics Market Forecast by Regions (2018-2023)
12.3 North America Long-Acting Injectable Antipsychotics Revenue Market Forecast (2018-2023)
12.4 Europe Long-Acting Injectable Antipsychotics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Long-Acting Injectable Antipsychotics Revenue Market Forecast (2018-2023)
12.6 South America Long-Acting Injectable Antipsychotics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Long-Acting Injectable Antipsychotics Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Long-Acting Injectable Antipsychotics Picture
Table Product Specifications of Long-Acting Injectable Antipsychotics
Table Global Long-Acting Injectable Antipsychotics and Revenue (Million USD) Market Split by Product Type
Figure Global Long-Acting Injectable Antipsychotics Revenue Market Share by Types in 2017
Figure Small and Middle Sized Molecule Picture
Figure Large Sized Molecule Picture
Table Global Long-Acting Injectable Antipsychotics Revenue (Million USD) by Application (2013-2023)
Figure Long-Acting Injectable Antipsychotics Revenue Market Share by Applications in 2017
Figure Schizophrenia Picture
Figure Other Psychotic Disorders Picture
Table Global Market Long-Acting Injectable Antipsychotics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Long-Acting Injectable Antipsychotics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Long-Acting Injectable Antipsychotics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Long-Acting Injectable Antipsychotics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Long-Acting Injectable Antipsychotics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Long-Acting Injectable Antipsychotics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Long-Acting Injectable Antipsychotics Revenue (Million USD) and Growth Rate (2013-2023)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Long-Acting Injectable Antipsychotics Type and Applications
Table Eli Lilly Long-Acting Injectable Antipsychotics Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Long-Acting Injectable Antipsychotics Type and Applications
Table Pfizer Long-Acting Injectable Antipsychotics Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Long-Acting Injectable Antipsychotics Type and Applications
Table GlaxoSmithKline Long-Acting Injectable Antipsychotics Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Long-Acting Injectable Antipsychotics Type and Applications
Table Johnson & Johnson Long-Acting Injectable Antipsychotics Revenue, Gross Margin and Market Share (2016-2017)
Table Lupin Limited Basic Information, Manufacturing Base and Competitors
Table Lupin Limited Long-Acting Injectable Antipsychotics Type and Applications
Table Lupin Limited Long-Acting Injectable Antipsychotics Revenue, Gross Margin and Market Share (2016-2017)
Table Zogenix Basic Information, Manufacturing Base and Competitors
Table Zogenix Long-Acting Injectable Antipsychotics Type and Applications
Table Zogenix Long-Acting Injectable Antipsychotics Revenue, Gross Margin and Market Share (2016-2017)
Table DURECT Basic Information, Manufacturing Base and Competitors
Table DURECT Long-Acting Injectable Antipsychotics Type and Applications
Table DURECT Long-Acting Injectable Antipsychotics Revenue, Gross Margin and Market Share (2016-2017)
Table Medincel Basic Information, Manufacturing Base and Competitors
Table Medincel Long-Acting Injectable Antipsychotics Type and Applications
Table Medincel Long-Acting Injectable Antipsychotics Revenue, Gross Margin and Market Share (2016-2017)
Table Global Long-Acting Injectable Antipsychotics Revenue (Million USD) by Players (2013-2018)
Table Global Long-Acting Injectable Antipsychotics Revenue Share by Players (2013-2018)
Figure Global Long-Acting Injectable Antipsychotics Revenue Share by Players in 2016
Figure Global Long-Acting Injectable Antipsychotics Revenue Share by Players in 2017
Figure Global Top 5 Players Long-Acting Injectable Antipsychotics Revenue Market Share in 2017
Figure Global Top 10 Players Long-Acting Injectable Antipsychotics Revenue Market Share in 2017
Figure Global Long-Acting Injectable Antipsychotics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Long-Acting Injectable Antipsychotics Revenue (Million USD) by Regions (2013-2018)
Table Global Long-Acting Injectable Antipsychotics Revenue Market Share by Regions (2013-2018)
Figure Global Long-Acting Injectable Antipsychotics Revenue Market Share by Regions (2013-2018)
Figure Global Long-Acting Injectable Antipsychotics Revenue Market Share by Regions in 2017
Figure North America Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Figure Europe Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Figure South America Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Table North America Long-Acting Injectable Antipsychotics Revenue by Countries (2013-2018)
Table North America Long-Acting Injectable Antipsychotics Revenue Market Share by Countries (2013-2018)
Figure North America Long-Acting Injectable Antipsychotics Revenue Market Share by Countries (2013-2018)
Figure North America Long-Acting Injectable Antipsychotics Revenue Market Share by Countries in 2017
Figure USA Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Figure Canada Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Figure Mexico Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Table Europe Long-Acting Injectable Antipsychotics Revenue (Million USD) by Countries (2013-2018)
Figure Europe Long-Acting Injectable Antipsychotics Revenue Market Share by Countries (2013-2018)
Figure Europe Long-Acting Injectable Antipsychotics Revenue Market Share by Countries in 2017
Figure Germany Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Figure UK Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Figure France Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Figure Russia Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Figure Italy Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Long-Acting Injectable Antipsychotics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Long-Acting Injectable Antipsychotics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Long-Acting Injectable Antipsychotics Revenue Market Share by Countries in 2017
Figure China Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Figure Japan Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Figure Korea Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Figure India Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Table South America Long-Acting Injectable Antipsychotics Revenue by Countries (2013-2018)
Table South America Long-Acting Injectable Antipsychotics Revenue Market Share by Countries (2013-2018)
Figure South America Long-Acting Injectable Antipsychotics Revenue Market Share by Countries (2013-2018)
Figure South America Long-Acting Injectable Antipsychotics Revenue Market Share by Countries in 2017
Figure Brazil Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Figure Argentina Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Figure Colombia Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Long-Acting Injectable Antipsychotics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Long-Acting Injectable Antipsychotics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Long-Acting Injectable Antipsychotics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Long-Acting Injectable Antipsychotics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Figure UAE Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Figure Egypt Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Figure Nigeria Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Figure South Africa Long-Acting Injectable Antipsychotics Revenue and Growth Rate (2013-2018)
Table Global Long-Acting Injectable Antipsychotics Revenue (Million USD) by Type (2013-2018)
Table Global Long-Acting Injectable Antipsychotics Revenue Share by Type (2013-2018)
Figure Global Long-Acting Injectable Antipsychotics Revenue Share by Type (2013-2018)
Figure Global Long-Acting Injectable Antipsychotics Revenue Share by Type in 2017
Table Global Long-Acting Injectable Antipsychotics Revenue Forecast by Type (2018-2023)
Figure Global Long-Acting Injectable Antipsychotics Market Share Forecast by Type (2018-2023)
Figure Global Small and Middle Sized Molecule Revenue Growth Rate (2013-2018)
Figure Global Large Sized Molecule Revenue Growth Rate (2013-2018)
Table Global Long-Acting Injectable Antipsychotics Revenue by Application (2013-2018)
Table Global Long-Acting Injectable Antipsychotics Revenue Share by Application (2013-2018)
Figure Global Long-Acting Injectable Antipsychotics Revenue Share by Application (2013-2018)
Figure Global Long-Acting Injectable Antipsychotics Revenue Share by Application in 2017
Table Global Long-Acting Injectable Antipsychotics Revenue Forecast by Application (2018-2023)
Figure Global Long-Acting Injectable Antipsychotics Market Share Forecast by Application (2018-2023)
Figure Global Schizophrenia Revenue Growth Rate (2013-2018)
Figure Global Other Psychotic Disorders Revenue Growth Rate (2013-2018)
Figure Global Long-Acting Injectable Antipsychotics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Long-Acting Injectable Antipsychotics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Long-Acting Injectable Antipsychotics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Long-Acting Injectable Antipsychotics Revenue Market Forecast (2018-2023)
Figure Europe Long-Acting Injectable Antipsychotics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Long-Acting Injectable Antipsychotics Revenue Market Forecast (2018-2023)
Figure South America Long-Acting Injectable Antipsychotics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Long-Acting Injectable Antipsychotics Revenue Market Forecast (2018-2023)